SYF Stock Cash Flow Statements

Synchrony Financial Quarterly Cash Flow Statements Chart

Quarterly

Annual

Synchrony Financial Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30

cash flows - operating activities
net earnings	967,000,000	757,000,000	774,000,000	789,000,000	643,000,000	1,293,000,000	440,000,000	628,000,000	569,000,000	601,000,000	577,000,000	703,000,000	804,000,000	932,000,000	813,000,000	1,141,000,000	1,242,000,000	1,025,000,000	738,000,000	313,000,000	48,000,000	286,000,000	731,000,000	1,056,000,000	853,000,000	1,107,000,000	783,000,000	671,000,000	696,000,000	640,000,000	385,000,000	555,000,000	496,000,000	499,000,000	576,000,000	604,000,000	489,000,000	582,000,000	547,000,000	574,000,000	541,000,000	552,000,000	531,000,000	548,000,000
adjustments to reconcile net earnings to cash provided from operating activities
benefit from credit losses	1,146,000,000	1,491,000,000	1,561,000,000	1,597,000,000	1,691,000,000	1,884,000,000	1,804,000,000	1,488,000,000	1,383,000,000	1,290,000,000	1,201,000,000	929,000,000	724,000,000	521,000,000	561,000,000	25,000,000	-194,000,000	334,000,000	750,000,000	1,210,000,000	1,673,000,000	1,677,000,000
deferred income taxes	-23,000,000	54,000,000	-18,000,000	-72,000,000	-35,000,000	27,000,000	-187,000,000	-120,000,000	-63,000,000	-88,000,000	-236,000,000	-111,000,000	-123,000,000	49,000,000	-11,000,000	46,000,000	70,000,000	114,000,000	-134,000,000	-140,000,000	-219,000,000	-109,000,000	-80,000,000	-32,000,000	-10,000,000	145,000,000	0	-42,000,000	-30,000,000	19,000,000	199,000,000	367,000,000	-200,000,000	19,000,000	342,000,000	-50,000,000	-78,000,000	175,000,000	-263,000,000	-57,000,000	-61,000,000	86,000,000
depreciation and amortization	122,000,000	125,000,000	120,000,000	121,000,000	121,000,000	119,000,000	118,000,000	116,000,000	113,000,000	111,000,000	101,000,000	105,000,000	106,000,000	107,000,000	105,000,000	93,000,000	97,000,000	95,000,000	93,000,000	97,000,000	97,000,000	96,000,000	94,000,000	94,000,000	92,000,000	87,000,000	80,000,000	78,000,000	73,000,000	71,000,000	67,000,000	69,000,000	59,000,000	59,000,000	55,000,000	56,000,000	54,000,000	54,000,000	47,000,000	46,000,000	44,000,000	37,000,000	35,000,000	33,000,000
gain on sale of business			0	0	0	-1,069,000,000
all other operating activities	152,000,000	128,000,000	154,000,000	145,000,000	53,000,000	155,000,000	194,000,000	177,000,000	200,000,000	164,000,000	199,000,000	185,000,000	43,000,000	147,000,000	103,000,000	154,000,000	135,000,000	130,000,000	174,000,000	179,000,000	187,000,000	180,000,000	163,000,000	161,000,000	140,000,000	144,000,000	149,000,000	130,000,000	152,000,000	170,000,000	161,000,000	165,000,000	151,000,000	172,000,000	137,000,000	127,000,000	125,000,000	136,000,000	140,000,000	99,000,000	76,000,000	114,000,000	245,000,000	25,000,000
changes in operating assets and liabilities, net of effects of acquisitions and dispositions
increase in interest and fees receivable	-32,000,000	-33,000,000	-197,000,000	21,000,000	211,000,000	-2,000,000	-322,000,000	-140,000,000	-149,000,000	-34,000,000	-271,000,000	-209,000,000	218,000,000	65,000,000	-155,000,000	-17,000,000	308,000,000	288,000,000	-55,000,000	46,000,000	389,000,000	-41,000,000	39,000,000	-297,000,000	-213,000,000	80,000,000	-244,000,000	-52,000,000	0	16,000,000	-188,000,000	-14,000,000	-136,000,000	40,000,000	-324,000,000	-70,000,000	-98,000,000	63,000,000	-145,000,000	-213,000,000	61,000,000	134,000,000	-206,000,000
increase in other assets	-10,000,000	1,000,000	-112,000,000	115,000,000	-165,000,000	45,000,000	-30,000,000	161,000,000	-143,000,000	19,000,000	47,000,000	-37,000,000	23,000,000	-12,000,000	116,000,000	71,000,000	-237,000,000	87,000,000	104,000,000	-51,000,000	37,000,000	-71,000,000	47,000,000	111,000,000	-183,000,000	118,000,000	120,000,000	73,000,000	-260,000,000	148,000,000	223,000,000	-48,000,000	-262,000,000	231,000,000	-427,000,000	-13,000,000	6,000,000	36,000,000	62,000,000	107,000,000	-92,000,000	-7,000,000	67,000,000
increase in accrued expenses and other liabilities	238,000,000	-323,000,000	71,000,000	47,000,000	-35,000,000	-204,000,000	300,000,000	172,000,000	-2,000,000	-177,000,000	229,000,000	69,000,000	22,000,000	-413,000,000	472,000,000	302,000,000	20,000,000	-234,000,000	416,000,000	-171,000,000	169,000,000	-481,000,000	238,000,000	287,000,000	89,000,000	-251,000,000	236,000,000	376,000,000	255,000,000	-511,000,000	269,000,000	524,000,000	334,000,000	-576,000,000	601,000,000	175,000,000	-47,000,000	-449,000,000	678,000,000	59,000,000	4,000,000	62,000,000		47,000,000
cash provided from (used for) operating activities	2,560,000,000	2,200,000,000	2,353,000,000	2,763,000,000	2,484,000,000	2,248,000,000	2,317,000,000	2,482,000,000	1,908,000,000	1,886,000,000	1,847,000,000	1,634,000,000	1,817,000,000	1,396,000,000	2,004,000,000	1,815,000,000	1,441,000,000	1,839,000,000	2,086,000,000	1,483,000,000	2,381,000,000	1,537,000,000	2,336,000,000	2,399,000,000	1,966,000,000	2,289,000,000	2,576,000,000	2,685,000,000	2,166,000,000	1,915,000,000		2,928,000,000	1,768,000,000	1,750,000,000
cash flows - investing activities
maturity and sales of debt securities	350,000,000	855,000,000	655,000,000	765,000,000	1,214,000,000	982,000,000	1,129,000,000	1,864,000,000	560,000,000	1,458,000,000	325,000,000	852,000,000	809,000,000	1,998,000,000	831,000,000	413,000,000	1,322,000,000	2,514,000,000	3,440,000,000	716,000,000	3,052,000,000	1,175,000,000	1,319,000,000	2,669,000,000	1,883,000,000	2,214,000,000	1,707,000,000	1,293,000,000	1,950,000,000	718,000,000
purchases of debt securities	-526,000,000	-480,000,000	-1,389,000,000	-375,000,000	-884,000,000	-163,000,000	-1,981,000,000	-430,000,000	-821,000,000	-391,000,000	-242,000,000	-964,000,000	-1,182,000,000	-1,478,000,000	-700,000,000	-150,000,000	-519,000,000	-1,621,000,000	-2,490,000,000	-2,532,000,000	-3,509,000,000	-1,382,000,000	-2,678,000,000	-954,000,000	-2,261,000,000	-1,963,000,000	-466,000,000	-1,796,000,000	-2,463,000,000	-2,546,000,000
acquisitions, net of cash acquired			0	0	0	-1,935,000,000
proceeds from sale of business, net of cash and restricted cash sold			0	0	0	491,000,000
net increase in loan receivables, including held for sale	-1,821,000,000	3,428,000,000	-4,031,000,000	-2,453,000,000	-2,596,000,000	1,504,000,000	-6,103,000,000	-3,783,000,000	-4,780,000,000	-234,000,000	-6,734,000,000	-3,954,000,000	-4,460,000,000	1,415,000,000	-5,768,000,000	-1,984,000,000	-2,622,000,000	3,996,000,000	-4,085,000,000	-1,273,000,000	2,607,000,000	3,464,000,000	-6,017,000,000	-3,109,000,000	-2,667,000,000	3,760,000,000
all other investing activities	-244,000,000	-200,000,000	-198,000,000	-168,000,000	-241,000,000	-81,000,000	-214,000,000	-219,000,000	-148,000,000	-141,000,000	-207,000,000	-76,000,000	-149,000,000	-117,000,000	-127,000,000	-113,000,000	-57,000,000	-252,000,000	-124,000,000	-82,000,000	-105,000,000	-79,000,000	-146,000,000	-104,000,000	-137,000,000	-201,000,000	-187,000,000	-352,000,000	-187,000,000	-76,000,000	-91,000,000	-86,000,000	-55,000,000	-242,000,000	-85,000,000	-47,000,000	-36,000,000	-50,000,000	-141,000,000	-100,000,000	-92,000,000	-108,000,000
cash provided from (used for) investing activities	-2,241,000,000	3,603,000,000	-4,963,000,000	-2,231,000,000	-2,507,000,000	798,000,000	-7,169,000,000	-2,568,000,000	-5,189,000,000	692,000,000	-6,858,000,000	-4,142,000,000	-1,052,000,000	1,818,000,000	-5,764,000,000	-1,834,000,000	-1,853,000,000	4,637,000,000	-3,259,000,000	-3,171,000,000	2,045,000,000	3,887,000,000	681,000,000	-1,570,000,000	-3,182,000,000	3,810,000,000	-6,285,000,000	-10,477,000,000	-3,029,000,000	755,000,000		-1,288,000,000	-2,380,000,000	1,420,000,000
cash flows - financing activities
borrowings of consolidated securitization entities
proceeds from issuance of securitized debt	748,000,000	747,000,000	0	747,000,000	200,000,000	747,000,000	747,000,000	1,297,000,000	0	250,000,000	1,050,000,000	673,000,000			1,011,000,000	300,000,000	800,000,000	250,000,000	0	175,000,000	0	500,000,000	0	300,000,000	1,547,000,000	1,498,000,000	600,000,000	2,372,000,000	704,000,000	1,417,000,000	1,930,000,000	811,000,000	820,000,000	750,000,000	25,000,000	1,599,000,000	1,419,000,000	748,000,000	1,075,000,000	631,000,000	1,425,000,000	750,000,000	1,376,000,000	400,000,000
maturities and repayment of securitized debt			-175,000,000	-250,000,000			0	-300,000,000	-707,000,000	-250,000,000	-1,184,000,000	0	-1,450,000,000	-1,150,000,000	-11,000,000	-1,000,000,000	-1,007,000,000	-868,000,000	-1,000,000	-476,000,000	-1,183,000,000	-1,623,000,000	-500,000,000	-1,330,000,000	-1,700,000,000	-3,847,000,000	-350,000,000	-356,000,000	-750,000,000	-1,701,000,000	-1,326,000,000	-1,126,000,000	-1,050,000,000	-708,000,000	-50,000,000	-1,425,000,000	-1,609,000,000	-1,915,000,000	-1,112,000,000	-939,000,000	-1,294,000,000	-1,899,000,000
senior and subordinated unsecured notes
proceeds from issuance of senior and subordinated unsecured notes	-2,000,000	796,000,000	0				0	0	0	740,000,000
maturities and repayment of senior and subordinated unsecured notes			0	-1,250,000,000	0	-600,000,000
proceeds from issuance of preferred stock			0	0	0	488,000,000
dividends paid on preferred stock	-21,000,000	-21,000,000	-21,000,000	-21,000,000	-19,000,000	-11,000,000	-11,000,000	-10,000,000	-10,000,000	-11,000,000	-10,000,000	-11,000,000	-11,000,000	-10,000,000	-10,000,000	-11,000,000	-10,000,000	-11,000,000	-10,000,000	-10,000,000	-11,000,000	-11,000,000
net increase in deposits	-1,175,000,000	1,370,000,000	-241,000,000	-818,000,000	-458,000,000	2,396,000,000	3,083,000,000	2,298,000,000	1,336,000,000	2,720,000,000	3,328,000,000	3,691,000,000	1,132,000,000	1,302,000,000	1,913,000,000	510,000,000	-2,922,000,000	-35,000,000	-713,000,000	-659,000,000	-469,000,000	-528,000,000	-823,000,000	324,000,000	1,580,000,000	36,000,000	1,717,000,000	3,308,000,000	2,487,000,000	-3,000,000	2,030,000,000	1,582,000,000	1,276,000,000	-798,000,000	2,235,000,000	3,382,000,000	1,445,000,000	1,292,000,000	2,900,000,000	2,776,000,000	2,808,000,000	-211,000,000	2,266,000,000	2,227,000,000
purchases of treasury stock	-504,000,000	-605,000,000	-101,000,000	-302,000,000	-305,000,000	-300,000,000	-253,000,000	-152,000,000	-303,000,000	-404,000,000	-701,000,000	-950,000,000	-701,000,000	-968,000,000	-982,000,000	-1,301,000,000	-393,000,000	-200,000,000	0	0	0	-985,000,000	-1,376,000,000	-550,000,000	-725,000,000	-967,000,000	0	-967,000,000	-491,000,000	-410,000,000	-431,000,000	-390,000,000
dividends paid on common stock	-114,000,000	-97,000,000	-97,000,000	-99,000,000	-100,000,000	-102,000,000	-103,000,000	-104,000,000	-99,000,000	-100,000,000	-103,000,000	-109,000,000	-108,000,000	-114,000,000	-120,000,000	-124,000,000	-128,000,000	-128,000,000	-128,000,000	-129,000,000	-128,000,000	-135,000,000	-141,000,000	-145,000,000	-145,000,000	-150,000,000	-151,000,000	-156,000,000	-113,000,000	-114,000,000	-118,000,000	-118,000,000	-105,000,000	-105,000,000	-107,000,000
all other financing activities	1,000,000	-71,000,000	18,000,000	17,000,000	15,000,000	-14,000,000	10,000,000	2,000,000	-1,000,000	-33,000,000	0	-4,000,000	-4,000,000	-36,000,000	1,000,000	3,000,000	12,000,000	13,000,000	4,000,000	-1,000,000	-5,000,000	-5,000,000	15,000,000	3,000,000	11,000,000	8,000,000	-2,000,000	-28,000,000	-5,000,000	1,000,000	3,000,000	-4,000,000			1,000,000	-4,000,000			-5,000,000	-13,000,000	-8,000,000	-14,000,000
cash provided from (used for) financing activities	-2,817,000,000	2,119,000,000	-617,000,000	-1,231,000,000	-1,367,000,000	2,604,000,000	3,473,000,000	3,031,000,000	216,000,000	2,912,000,000	2,380,000,000	4,779,000,000	-899,000,000	-976,000,000	2,546,000,000	-1,623,000,000	-5,148,000,000	-979,000,000	-848,000,000	-1,100,000,000	-1,796,000,000	-4,287,000,000	-2,091,000,000	-1,253,000,000	68,000,000	-3,182,000,000	1,814,000,000	4,173,000,000	2,579,000,000	-313,000,000		255,000,000	1,240,000,000	-1,099,000,000
increase in cash and equivalents, including restricted amounts	-2,498,000,000	7,922,000,000		-699,000,000	-1,390,000,000	5,650,000,000		2,945,000,000	-3,065,000,000	5,490,000,000	-2,631,000,000	2,271,000,000	-134,000,000	2,238,000,000	-1,214,000,000	-1,642,000,000	-5,560,000,000	5,497,000,000	-2,021,000,000	-2,788,000,000	2,630,000,000	1,137,000,000	926,000,000	-424,000,000	-1,148,000,000	2,917,000,000	-1,895,000,000	-3,619,000,000	1,716,000,000	2,357,000,000
cash and equivalents, including restricted amounts, at beginning of period	0	14,755,000,000		0	-1,000,000	14,421,000,000		0	0	10,430,000,000		0	0	8,686,000,000		0	1,000,000	11,604,000,000		0	0	12,647,000,000		0	0	10,376,000,000	0	0	0	11,817,000,000
cash and equivalents at end of period:
cash and equivalents	-2,172,000,000	21,629,000,000	-3,223,000,000	-698,000,000	-1,389,000,000	20,021,000,000	-1,384,000,000	2,937,000,000	-2,597,000,000	15,303,000,000	-1,668,000,000	1,280,000,000	141,000,000	10,541,000,000	-1,469,000,000	-1,311,000,000	-5,503,000,000	16,620,000,000	-2,028,000,000	-2,792,000,000	2,640,000,000	13,704,000,000	686,000,000	-294,000,000	-1,208,000,000	12,963,000,000	-2,672,000,000	-3,607,000,000	2,631,000,000	13,044,000,000
restricted cash and equivalents included in other assets	-326,000,000	1,048,000,000	-3,000,000	-1,000,000	-2,000,000	50,000,000	-107,000,000	8,000,000	-468,000,000	617,000,000	-963,000,000	991,000,000	-275,000,000	383,000,000	255,000,000	-331,000,000	-56,000,000	481,000,000	7,000,000	4,000,000	-10,000,000	80,000,000	240,000,000	-130,000,000	60,000,000	330,000,000	777,000,000	-12,000,000	-915,000,000	1,130,000,000
total cash and equivalents, including restricted amounts, at end of period	-2,498,000,000	22,677,000,000		-699,000,000	-1,391,000,000	20,071,000,000		2,945,000,000	-3,065,000,000	15,920,000,000		2,271,000,000	-134,000,000	10,924,000,000		-1,642,000,000	-5,559,000,000	17,101,000,000		-2,788,000,000	2,630,000,000	13,784,000,000		-424,000,000	-1,148,000,000	13,293,000,000		-3,619,000,000	1,716,000,000	14,174,000,000
u.s. government and federal agency	298,000,000	1,500,000,000						-1,735,000,000	102,000,000	3,078,000,000	154,000,000	769,000,000	632,000,000	2,362,000,000	-301,000,000	-8,000,000	-458,000,000	2,989,000,000	-1,272,000,000	2,000,000,000	520,000,000	2,678,000,000	1,272,000,000	-1,617,000,000	529,000,000	2,284,000,000	-1,411,000,000	544,000,000	395,000,000	3,361,000,000	694,000,000	-851,000,000	-1,298,000,000	3,874,000,000	1,576,000,000	300,000,000	-764,000,000	2,564,000,000	-429,000,000	-76,000,000	527,000,000	2,746,000,000
state and municipal	10,000,000	16,000,000						0	0	10,000,000	0	-1,000,000	0	11,000,000	-22,000,000	-2,000,000	0	37,000,000	0	-4,000,000	0	44,000,000	-1,000,000	-1,000,000	0	48,000,000	10,000,000	-2,000,000	0	42,000,000	0	-1,000,000	1,000,000	44,000,000	0	-2,000,000	0	49,000,000	0	-4,000,000	0	55,000,000
residential mortgage-backed	-16,000,000	326,000,000						-13,000,000	-23,000,000	447,000,000	-23,000,000	-28,000,000	-37,000,000	555,000,000	-52,000,000	-47,000,000	-73,000,000	769,000,000	13,000,000	-90,000,000	-72,000,000	966,000,000	-78,000,000	-11,000,000	-30,000,000	1,148,000,000	-36,000,000	-67,000,000	44,000,000	1,239,000,000	-63,000,000	-63,000,000	-40,000,000	1,424,000,000	217,000,000	335,000,000	529,000,000	319,000,000		-9,000,000	40,000,000	304,000,000
asset-backed	-114,000,000	892,000,000						333,000,000	201,000,000	556,000,000	-352,000,000	-625,000,000	-225,000,000	1,801,000,000	226,000,000	-227,000,000	-288,000,000	2,721,000,000	299,000,000	-97,000,000	13,000,000	2,437,000,000	132,000,000	62,000,000	125,000,000	2,049,000,000	197,000,000	34,000,000	85,000,000	1,672,000,000	550,000,000
other	0	8,000,000						0	0	8,000,000	0	0	0	8,000,000	0	5,000,000	0	8,000,000
total	178,000,000	2,742,000,000	0	0	0	1,934,000,000		-1,415,000,000	280,000,000	4,099,000,000	-221,000,000	115,000,000	370,000,000	4,737,000,000	-149,000,000	-279,000,000	-819,000,000	6,524,000,000	-960,000,000	1,809,000,000	461,000,000	6,125,000,000	1,325,000,000	-1,567,000,000	622,000,000	5,531,000,000	-1,240,000,000	509,000,000	524,000,000	6,316,000,000	1,183,000,000	-684,000,000	-1,337,000,000	5,357,000,000	1,793,000,000	633,000,000	-235,000,000	2,947,000,000	-441,000,000	-89,000,000	567,000,000	3,120,000,000
proceeds from sale of loan receivables											0	0			0	0			0	0	0	709,000,000																	0	0
increase in cash and equivalents, including restricted and held for sale amounts
cash and equivalents, including restricted amounts, at beginning of year
cash and equivalents at end of year:
cash and equivalents, including restricted amounts, held for sale
total cash and equivalents, including restricted and held for sale amounts, at end of year
supplemental disclosure of cash flow information
cash paid during the year for interest
cash paid during the year for income taxes
assets acquired
cash			0	0	0	34,000,000
loan receivables			0	0	0	1,875,000,000
intangible assets			0	0	0	23,000,000
other assets			0	0	0	2,000,000
liabilities assumed
other liabilities			0	0	0	-16,000,000
total net identifiable assets acquired			0	0	0	1,918,000,000
less: total cash consideration paid			0	0	0	1,969,000,000
goodwill			0	0	0	51,000,000
at december 31
assets
total assets held for sale
liabilities
total liabilities held for sale
senior unsecured notes
proceeds from issuance of senior unsecured notes											0	1,489,000,000											0	745,000,000
maturities and repayment of senior unsecured notes											0	0			0	0			0	0	0	-1,500,000,000	0	-600,000,000
total cash and equivalents, including restricted amounts, at end of year
acquisition of loan receivables																							0				-841,000,000				-360,000,000	0	0	-73,000,000	0	0	0	-54,000,000	5,000,000	-125,000,000
benefit from loan losses																							1,104,000,000	1,019,000,000	1,198,000,000	859,000,000	1,452,000,000	1,451,000,000	1,280,000,000	1,362,000,000	1,354,000,000	1,310,000,000	1,326,000,000	1,306,000,000	1,076,000,000	986,000,000	1,021,000,000	903,000,000	823,000,000	702,000,000	740,000,000	687,000,000	797,000,000	675,000,000
u.s. corporate debt																										2,000,000	0	0	0	2,000,000
third-party debt
proceeds from issuance of third-party debt																										1,240,000,000	0	0	747,000,000	497,000,000	991,000,000	0			0	695,000,000			1,000,000,000	997,000,000	0	998,000,000
maturities and repayment of third-party debt																										-1,000,000,000					-700,000,000				0	0	-1,500,000,000	-2,651,000,000	-500,000,000	-500,000,000	-500,000,000	-2,594,000,000
net increase in loan receivables																											-6,498,000,000	-2,280,000,000	-2,329,000,000	2,659,000,000	-5,532,000,000	-2,527,000,000	-3,097,000,000	1,918,000,000	-6,319,000,000	-3,160,000,000	-3,171,000,000	1,558,000,000	-5,419,000,000	-2,467,000,000	-3,090,000,000	2,124,000,000
cash from operating activities																																											1,046,000,000	1,295,000,000
maturity and sales of investment securities
purchases of investment securities																															-1,912,000,000	-281,000,000	-344,000,000	-622,000,000	-2,139,000,000	-676,000,000	-552,000,000	-13,000,000	-355,000,000	-1,624,000,000	-1,284,000,000	-1,839,000,000
net increase in restricted cash and equivalents																															-42,000,000	694,000,000	-560,000,000	40,000,000	32,000,000	-75,000,000	540,000,000	-453,000,000	-74,000,000	-16,000,000	-53,000,000	856,000,000
cash (used for) from investing activities
related party debt
maturities and repayment of related party debt																																							0	0	0	-655,000,000
cash from (used for) financing activities																																					251,000,000	-2,526,000,000	3,358,000,000	2,952,000,000	2,431,000,000	-3,625,000,000	2,131,000,000	9,627,000,000
increase in cash and equivalents																															-2,313,000,000	1,895,000,000	628,000,000	2,071,000,000	-4,267,000,000	1,801,000,000	-713,000,000	175,000,000	54,000,000	1,650,000,000	-597,000,000	-610,000,000	-2,980,000,000	8,026,000,000
cash and equivalents at beginning of year
cash and equivalents at end of year
debt
equity																															0	0	0	15,000,000	0	0	0	15,000,000	0	0	0	15,000,000
maturity and redemption of investment securities																																912,000,000	1,676,000,000	399,000,000	342,000,000	42,000,000	783,000,000	213,000,000	791,000,000	1,713,000,000	717,000,000	317,000,000	8,000,000	9,000,000
cash and equivalents at beginning of period																																0	0	9,321,000,000		0	0	12,325,000,000		0	0	11,828,000,000		0
cash and equivalents at end of period																																1,895,000,000	628,000,000	11,392,000,000		1,801,000,000	-713,000,000	12,500,000,000		1,650,000,000	-597,000,000	11,218,000,000		8,026,000,000
purchase of treasury stock																																		-238,000,000
proceeds from borrowings of related party debt																																											0
proceeds from initial public offering																																											0
net transfers (to) from parent
cash from (used for) operating activities																																					1,472,000,000	1,500,000,000		1,317,000,000	1,313,000,000	1,665,000,000
cash from (used for) investing activities																																					-2,436,000,000	1,201,000,000		-2,619,000,000	-4,341,000,000	1,350,000,000
net cash from principal business purchased
residential
mortgage-backed
net transfers to parent
third party debt
proceeds from issuance of third party debt
maturities and repayment of third party debt
note 1.
decrease in interest and fee receivable
decrease (increase) in other assets
net increase in restricted cash
net decrease in related party debt

We provide you with 20 years of cash flow statements for Synchrony Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Synchrony Financial stock. Explore the full financial landscape of Synchrony Financial stock with our expertly curated income statements.

The information provided in this report about Synchrony Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.